Healthcare - Biotechnology - NASDAQ - US
$ 9.905
-11.1 %
$ 618 M
Market Cap
-1.31
P/E
INCOME STATEMENT
14 M
REVENUE
-110 M
OPERATING INCOME
-107 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Immunome, Inc.
| Revenue | 14 M |
| Cost Of Revenue | 22.9 M |
| Gross Profit | -8.91 M |
| Operating Expenses | 123 M |
| Operating Income | -110 M |
| Other Expenses | -2.72 M |
| Net Income | -107 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 14.0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 22.9 | 0.6 | 0.8 | 0.8 | 0.6 | 0.5 |
| Gross Profit | (8.9) | (0.6) | (0.8) | (0.8) | (0.6) | (0.5) |
| OPERATING INCOME | ||||||
| Operating Expenses | 122.8 | 36.9 | 25.2 | 12.3 | 10.3 | 7.7 |
| Selling, General and Administrative Expenses | 19.7 | 13.6 | 11.1 | 4.8 | 1.5 | 0.9 |
| Research and Development Expenses | 80.8 | 23.3 | 14.1 | 7.5 | 8.8 | 6.9 |
| Operating Income | (109.5) | (36.9) | (25.2) | (12.3) | (10.3) | (7.7) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 5 K | 10 K | 38 K | 0.1 | 0.1 |
| Total Other Income | 2.7 | 5 K | 0.5 | (5.6) | 96 K | (0.1) |
| Pre-Tax Income | (106.8) | (36.9) | (24.7) | (17.8) | (10.4) | (7.8) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0.6 | (0.2) | (0.7) | 0.1 | 39 K |
| Net Income | (106.8) | (37.5) | (24.5) | (17.1) | (10.6) | (7.8) |
| EPS | 5.38 | 3.09 | 2.12 | 5.05 | 1.84 | 1.79 |